Evidence map›Paper›PMID 34143831›Full record

Trial reportPloS one2021

Is biological larviciding against malaria a starting point for integrated multi-disease control? Observations from a cluster randomized trial in rural Burkina Faso.

Peter Dambach, Till Bärnighausen, Anges Yadouleton, Martin Dambach, Issouf Traoré, Patricia Korir, Saidou Ouedraogo, Moustapha Nikiema, Rainer Sauerborn, Norbert Becker and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Larviciding intervention targeting malaria vectors also affectsCurrent research in parasitology & vector-borne diseases · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Peter DambachInstitute for Global Health, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0002-1086-6866
Till BärnighausenInstitute for Global Health, University Hospital Heidelberg, Heidelberg, Germany.
Anges YadouletonCentre de Recherche Entomologique de Cotonou (CREC), Cotonou, Benin.
Martin DambachInstitute of Zoology, University of Cologne, Cologne, Germany.
Issouf TraoréCentre de Recherche en Santé de Nouna, Nouna, Burkina Faso.
Patricia KorirInstitute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.
Saidou OuedraogoCentre de Recherche en Santé de Nouna, Nouna, Burkina Faso.
Moustapha NikiemaCentre de Recherche en Santé de Nouna, Nouna, Burkina Faso.
Rainer SauerbornInstitute for Global Health, University Hospital Heidelberg, Heidelberg, Germany.
Norbert BeckerGerman Mosquito Control Association (KABS), Speyer, Germany.
Valérie R LouisInstitute for Global Health, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0002-0186-5028

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the impact of anti-malaria biological larviciding with Bacillus thuringiensis israelensis on non-primary target mosquito species in a rural African setting.

methodsA total of 127 villages were distributed in three study arms, each with different larviciding options in public spaces: i) no treatment, ii) full or iii) guided intervention. Geographically close villages were grouped in clusters to avoid contamination between treated and untreated villages. Adult mosquitoes were captured in light traps inside and outside houses during the rainy seasons of a baseline and an intervention year. After enumeration, a negative binomial regression was used to determine the reductions achieved in the different mosquito species through larviciding.

resultsMalaria larviciding interventions showed only limited or no impact against Culex mosquitoes; by contrast, reductions of up to 34% were achieved against Aedes when all detected breeding sites were treated. Culex mosquitoes were captured in high abundance in semi-urban settings while more Aedes were found in rural villages.

conclusionsFuture malaria larviciding programs should consider expanding onto the breeding habitats of other disease vectors, such as Aedes and Culex and evaluate their potential impact. Since the major cost components of such interventions are labor and transport, other disease vectors could be targeted at little additional cost.

Indexed as

LarvaMalariaMosquito ControlPest Control, BiologicalAnimalsBurkina FasoHumansRural Population

Identifiers

PMID34143831
PMCPMC8213177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.